Meanwhile, depletion of Aurora A sensitizing MM cells to BTZ treatment was also evidenced by more apoptosis through flow cytometry assay (Figure 5G,H), and more cleaved PARP following suppressed NSD2 level according to gradient BTZ concentration (Figure 5I). This evidence concerns the gene NSD2 and Miyoshi myopathy.